Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -5.00M
June 30, 2026 0.30M
March 31, 2026 4.70M
December 31, 2025 8.46M
September 30, 2025 4.402M
June 30, 2025 4.675M
March 31, 2025 19.83M
December 31, 2024 12.74M
September 30, 2024 -4.824M
June 30, 2024 19.02M
March 31, 2024 -3.569M
December 31, 2023 -62.35M
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 5.00M
December 31, 2022 -0.935M
September 30, 2022 -0.086M
June 30, 2022 0.00
March 31, 2022 16.69M
December 31, 2021 0.00
Date Value
September 30, 2021 0.00
June 30, 2021 1.027M
March 31, 2021 0.00
December 31, 2020 2.002M
September 30, 2020 0.00
June 30, 2020 21.12M
March 31, 2020 65.98M
December 31, 2019 6.034M
September 30, 2019 -4.677M
June 30, 2019 32.77M
March 31, 2019 7.739M
December 31, 2018 -4.071M
September 30, 2018 8.296M
June 30, 2018 7.677M
March 31, 2018 -45.78M
December 31, 2017 6.311M
September 30, 2017 -36.31M
June 30, 2017 7.349M
March 31, 2017 7.587M
December 31, 2016 1.156M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -6.00M
Cue Biopharma, Inc. 0.00
Faeth Therapeutics, Inc. 0.175M
Indaptus Therapeutics, Inc. 0.0882M
Pyxis Oncology, Inc. -37.29M